|
Match
|
Document |
Document Title |
|
|
US20090292039 |
OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING THE SAME
Disclosed is an oxime ester compound represented by the following general formula (I). (In the formula, R 1 , R 2 and R 3 independently represent R 11 , OR 11 , COR 11 , SR 11 , CONR 12 R 13 or...
|
|
|
US20090286991 |
PROCESS FOR THE PREPARATION OF CARVEDILOL FORM II
A cost-effective, industrially feasible process for the manufacture of crystalline Carvedilol Form-II using novel Carvedilol salts comprises the steps of reacting 4-(2,3-epoxy propoxy)carbazole...
|
|
|
US20090286845 |
Carvedilol phosphate
The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel...
|
|
|
US20090286844 |
Carvedilol phosphate
The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel...
|
|
|
US20090259051 |
CARVEDILOL PHOSPHATE SESQUIHYDRATE
The present invention relates a novel crystalline 1-(Carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol phosphate sesquihydrate (Carvedilol dihydrogenphosphate sesquihydrate),...
|
|
|
US20090176941 |
Functionalized Polymers Using Protected Thiols
A process for the preparation of functional molecules using the thiol-ene coupling reaction and a process for the preparation of protected functional thiols, specifically thioesters is provided....
|
|
|
US20090167166 |
MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to compounds according to formula (1) and/or according to formulae (4) to (10) and their use in organic electroluminescent devices, in particular as a matrix material...
|
|
|
US20090134784 |
CARBAZOLE-CONTAINING MATERIALS IN PHOSPHORESCENT LIGHT EMITTING DIODES
Carbazole-containing compounds are provided. In particular, the compounds are oligocarbazole-containing compounds having an unsymmetrical structure. The compounds may be useful in organic light...
|
|
|
US20090102360 |
ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE
The present invention provides an anthracene derivative represented by the following general formula (1). In the general formula (1), R1 and R2 individually represent hydrogen or an alkyl group...
|
|
|
US20090076283 |
Method of crystallizing carvedilol phosphate and the product thereof
The present invention provides for a crystalline polymorph of Carvedilol phosphate salt and a process for making the same.
|
|
|
US20090042114 |
Halogenated oxime derivatives and the use therof as latent acids
Compounds of the formula I or II
wherein R 1 is C 1 -C 10 haloalkylsulfonyl, halobenzenesulfonyl, C 2 -C 10 haloalkanoyl, halobenzoyl; R 2 is halogen or C 1 -C 10 haloalkyl; Ar 1 is phenyl,...
|
|
|
US20090039765 |
LIGHT EMITTING POLYMER COMPOSITION AND POLYMER LIGHT EMITTING DEVICE
A light emitting polymer composition comprising a light emitting polymer and a compound selected from the following formulae (1a) to (1d):
(wherein, X represents an atom or atomic group...
|
|
|
US20090023085 |
Photosensitive Compositions, Curable Compositions, Novel Compounds, Photopolymerizable Compositions, Color Filters, and Planographic Printing Plate Precursors
A photosensitive composition includes a compound represented by Formula (I) and a curable composition contains the compound of Formula (I) and a polymerizable compound. A compound is represented by...
|
|
|
US20090005429 |
PROCESS FOR THE PREPARATION OF CARVEDILOL AND ITS ENANTIOMERS
The present invention relates to a process for the preparation of carvedilol as well as of the optically active R and S enantiomers thereof and of mixtures of these enantiomers and, more...
|
|
|
US20080312453 |
Novel Carbazole Compound, and Polymer Thereof
The present invention provides a carbazole compound represented by the following formula (I):
wherein each Ar 1 independently represents a substituted or unsubstituted monovalent aromatic group...
|
|
|
US20080287688 |
Efficient Process For Production Of Carvedilol Phosphate
A novel cost effective process for the synthesis of phosphate salts of 1-(9H-carbazol-4yloxy)-3-[[2-(2-methoxyphenoxy)ethyl] amino]-propan-2-ol, (carvedilol phosphate) of formula (II) with high...
|
|
|
US20080275083 |
2,3,4,9-TETRAHYDRO-1H-CARBAZOLES
The present invention relates to 2,3,4,9-tetrahydro-1H-carbazoles of the general formula I,
in which Q, X, W, R1, R2, R3, R4 and R5 have the meaning as defined in the description. The compounds...
|
|
|
US20080268284 |
ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED
An anthracene derivative represented by a general formula (1) and an organic compound represented by a general formula (8) are provided. Further, by use of the anthracene derivative represented by...
|
|
|
US20080255169 |
Sulphonamide Derivatives
The invention relates to sulphonamide derivatives of formula (I),
where
R C is optionally substituted 4-6-membered heterocyclic ring containing one or more N atoms, or R C forms together with...
|
|
|
US20080242872 |
AMORPHOUS CARVEDILOL PHOSPHATE AND METHOD OF MANUFACTURING THEREOF
The subject of the invention is amorphous carvedilol phosphate and a method of manufacturing amorphous carvedilol phosphate comprising removing solvent from carvedilol phosphate solution by means...
|
|
|
US20080234492 |
Process for the Preparation of Carvedilol
A process for the preparation of carvedilol of formula (I) (I) either in enantiomeric substantially pure form, or as an enantiomeric mixture, optionally as a pharmaceutically acceptable salt...
|
|
|
US20080214833 |
Process For Manufacture of Racemic Carvedilol
The invention relates to a novel process for the manufacture of Carvedilol of high HPLC purity (>99.5%) having individual impurity less than 0.1%. The product is isolated from reaction mass as a...
|
|
|
US20080207726 |
Process for the purification of carvedilol or its salts thereof
The present invention provides processes for reducing bis impurities ((1,1′-[2-(2-methoxyphenoxy)ethyl]iminobis-[3-(9H-carbazol
-4-yloxy)]-propan-2-ol)), in particular Bis 1 and Bis 2, in...
|
|
|
US20080194838 |
CARVEDILOL
This invention relates to an improved process of preparing carvedilol, as well as a new crystalline hydrate and solvate and forms of carvedilol, processes for the manufacture thereof, and...
|
|
|
US20080177084 |
IRIDIUM COMPLEX, CARBAZOLE DERIVATIVES AND COPOLYMER HAVING THE SAME
Disclosed are a monomer of iridium complex having a fluoro group as a functional group, a monomer of carbazole derivative having a hydroxy group as the functional group, and a copolymer containing...
|
|
|
US20080176849 |
DEACETYLASE INHIBITORS
The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
|
|
|
US20080167477 |
NOVEL POLYMORPHIC FORMS OF CARVEDILOL DIHYDROGEN PHOSPHATE AND PROCESS FOR PREPARING THE SAME
The present invention provides novel crystalline polymorphic forms and amorphous form of carvedilol dihydrogen phosphate characterized by different solid state techniques. The novel processes for...
|
|
|
US20080146544 |
LISOFYLLINE ANALOGS AND METHODS FOR USE
The present invention provides analogs of a Lysofylline (LSF), and synthetic methods for the preparation of such analogs. The have the active side chain moiety (5-R-hydroxyhexyl) of LSF and can...
|
|
|
US20080125476 |
Carvedilol phosphate
The invention encompasses novel amorphous and crystalline forms of carvedilol phosphate, carvedilol hydrogen phosphate, and carvedilol dihydrogen phosphate as well as methods of making the novel...
|
|
|
US20080096875 |
THIOUREA COMPOUNDS
This invention relates to thiourea compounds of formula (II) shown below:
Each variable in formula (I) is defined in the specification. These compounds can be used to treat hepatitis C virus...
|
|
|
US20080093987 |
Organoelectroluminescent compound and organoelectroluminescent device employing the same
A cyclopentaphenanthrene-based compound is easy to prepare and excellent in solubility, color purity, color stability, and thermal stability. The cyclopentaphenanthrene-based compound is useful as...
|
|
|
US20080093980 |
Organic Electroluminescent Device
The present invention relates to novel truxene and isotruxene derivatives, in particular spirotruxene and spiroisotruxene derivatives, and to the use thereof in organic electronic devices, in...
|
|
|
US20080086012 |
Anthracene Derivative, And Light Emitting Element, Light Emitting Device, And Electronic Device Using the Anthracene Derivative
It is an object to provide a noble anthracene derivative, a light emitting element with a high luminous efficiency, and further a light emitting element with a long lifetime. It is another object...
|
|
|
US20080085458 |
Oxime Derivatives And Use Thereof As Latent Acids
The invention pertain to novel photoacid generator compounds of the formula I, II or III
wherein
R 1 is for example C 1 -C 18 alkylsulfonyl or phenylsulfonyl, phenyl-C 1 -C 3 alkylsulfonyl,...
|
|
|
US20080064662 |
Methods and compositions for modulating sphingosine -1- phosphate (S1P) receptor activity
The present invention relates to compounds which modulate the activity of the S1P1 receptor, the use of these compounds for treating conditions associated with signaling through the S1P1 receptor,...
|
|
|
US20080051321 |
Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
Disclosed is the preparation and pharmaceutical use of substituted arylalcanoic acid derivatives of Formula I, wherein ring A, ring B, R 1 , R 2 , R 3 , R 4 , R 5 , X, Alk 1 , Alk 2 , Ar 1 , and Ar...
|
|
|
US20080021005 |
Pegylated Ion Channel Modulating Compounds
This invention is directed to PEGlyated derivatives, drug conjugates and isotopic derivatives of certain ion channel modulating compounds. Pharmaceutical compositions and methods of use of also...
|